Studies on membrane topology, N-glycosylation and functionality of SARS-CoV membrane protein

Virology Journal

Volumn 6, Issue , 2009, Pages

  Voß, Daniel ^a,b   Pfefferle, Susanne ^c   Drosten, Christian ^c,d   Stevermann, Lea ^a   Traggiai, Elisabetta ^e   Lanzavecchia, Antonio ^e   Becker, Stephan ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b ROBERT KOCH INSTITUTE   (Germany)

^c BERNHARD NOCHT INSTITUTE FOR TROPICAL MEDICINE   (Germany)

^d UNIVERSITY OF BONN   (Germany)

^e INSTITUTE FOR RESEARCH IN BIOMEDICINE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

M PROTEIN; PROTEIN S; RECOMBINANT PROTEIN; VIRUS ENVELOPE PROTEIN; VIRUS SPIKE PROTEIN; M PROTEIN, CORONAVIRUS; MATRIX PROTEIN; MEMBRANE PROTEIN; SPIKE GLYCOPROTEIN, CORONAVIRUS;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; BIOCHEMISTRY; CARBOXY TERMINAL SEQUENCE; CELL BUDDING; CELL CULTURE; CELL ORGANELLE; CONTROLLED STUDY; ENDOPLASMIC RETICULUM GOLGI INTERMEDIATE COMPARTMENT; GLYCOSYLATION; GOLGI COMPLEX; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOGENICITY; INFECTION; MEMBRANE STRUCTURE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEIN FUNCTION; SARS CORONAVIRUS; VIRION; VIRUS ASSEMBLY; AMINO ACID SUBSTITUTION; ANIMAL; CELL LINE; CERCOPITHECUS; CHEMISTRY; GENE DELETION; GENETICS; METABOLISM; PHYSIOLOGY; SITE DIRECTED MUTAGENESIS; VIROLOGY; VIRUS ENTRY; VIRUS REPLICATION;

CORONAVIRUS; SARS CORONAVIRUS;

AMINO ACID SUBSTITUTION; ANIMALS; CELL LINE; CERCOPITHECUS AETHIOPS; GLYCOSYLATION; GOLGI APPARATUS; HUMANS; MEMBRANE GLYCOPROTEINS; MUTAGENESIS, SITE-DIRECTED; SARS VIRUS; SEQUENCE DELETION; VIRAL ENVELOPE PROTEINS; VIRAL MATRIX PROTEINS; VIRUS INTERNALIZATION; VIRUS REPLICATION;

EID: 68149126710     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-6-79     Document Type: Article

References (49)

1. Development of protection against coronavirus induced diseases. A review. L Enjuanes C Smerdou J Castilla IM Anton JM Torres I Sola J Golvano JM Sanchez B Pintado, Adv Exp Med Biol 1995 380 197 211 8830481
2. Signs and symptoms in common colds. DA Tyrrell S Cohen JE Schlarb, Epidemiol Infect 1993 111 143 156 10.1017/S0950268800056764 8394240
3. Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus. SR Weiss S Navas-Martin, Microbiol Mol Biol Rev 2005 69 635 664 16339739 10.1128/MMBR.69.4.635-664.2005 (Pubitemid 41798466)
4. China culls wild animals to prevent new SARS threat. J Watts, Lancet 2004 363 134 10.1016/S0140-6736(03)15313-5 14733188
5. Update: Outbreak of severe acute respiratory syndrome worldwide, 2003. WHO, MMWR Morb Mortal Wkly Rep 2003 52 241 246 12680518
6. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. C Drosten S Gunther W Preiser S Werf HR Brodt S Becker H Rabenau M Panning L Kolesnikova RA Fouchier, N Engl J Med 2003 348 1967 1976 10.1056/NEJMoa030747 12690091 (Pubitemid 36569985)
7. Aetiology: Koch's postulates fulfilled for SARS virus. RA Fouchier T Kuiken M Schutten G van Amerongen GJ van Doornum BG van der Hoogen M Peiris W Lim K Stohr AD Osterhaus, Nature 2003 423 240 10.1038/423240a 12748632 (Pubitemid 40852688)
8. A novel coronavirus associated with severe acute respiratory syndrome. TG Ksiazek D Erdman CS Goldsmith SR Zaki T Peret S Emery S Tong C Urbani JA Comer W Lim, N Engl J Med 2003 348 1953 1966 10.1056/NEJMoa030781 12690092 (Pubitemid 36569984)
9. The financial impact of controlling a respiratory virus outbreak in a teaching hospital: lessons learned from SARS. C Achonu A Laporte MA Gardam, Can J Public Health 2005 96 52 54 15682697
10. The economic impact of quarantine: SARS in Toronto as a case study. AG Gupta CA Moyer DT Stern, J Infect 2005 50 386 393 10.1016/j.jinf.2004.08.006 15907545 (Pubitemid 40692022)
11. Coronavirus M proteins accumulate in the Golgi complex beyond the site of virion budding. J Klumperman JK Locker A Meijer MC Horzinek HJ Geuze PJ Rottier, J Virol 1994 68 6523 6534 8083990
12. Envelope glycoprotein interactions in coronavirus assembly. DJ Opstelten MJ Raamsman K Wolfs MC Horzinek PJ Rottier, J Cell Biol 1995 131 339 349 7593163 10.1083/jcb.131.2.339
13. Replication of coronavirus MHV-A59 in sac-cells: determination of the first site of budding of progeny virions. J Tooze S Tooze G Warren, Eur J Cell Biol 1984 33 281 293 6325194
14. Sequence and topology of a model intracellular membrane protein, E1 glycoprotein, from a coronavirus. J Armstrong H Niemann S Smeekens P Rottier G Warren, Nature 1984 308 751 752 10.1038/308751a0 6325918
15. Membrane protein molecules of transmissible gastroenteritis coronavirus also expose the carboxy-terminal region on the external surface of the virion. C Risco IM Anton C Sune AM Pedregosa JM Martin-Alonso F Parra JL Carrascosa L Enjuanes, J Virol 1995 69 5269 5277 7636969
16. Predicted membrane topology of the coronavirus protein E1. PJ Rottier GW Welling S Welling-Wester HG Niesters JA Lenstra BA Van der Zeijst, Biochemistry 1986 25 1335 1339 10.1021/bi00354a022 3008826
17. Characterization of severe acute respiratory syndrome coronavirus membrane protein. D Voss A Kern E Traggiai M Eickmann K Stadler A Lanzavecchia S Becker, FEBS Lett 2006 580 968 973 10.1016/j.febslet.2006.01.026 16442106 (Pubitemid 43152321)
18. Differential maturation and subcellular localization of severe acute respiratory syndrome coronavirus surface proteins S, M and E. B Nal C Chan F Kien L Siu J Tse K Chu J Kam I Staropoli B Crescenzo-Chaigne N Escriou, J Gen Virol 2005 86 1423 1434 10.1099/vir.0.80671-0 15831954 (Pubitemid 40613260)
19. Determination of the distance between the oligosaccharyltransferase active site and the endoplasmic reticulum membrane. IM Nilsson G von Heijne, J Biol Chem 1993 268 5798 5801 8449946
20. Characterisation of a patient-derived mutant of SARS-CoV by a novel T7 promoter-driven infectious cDNA clone. S Pfefferle K Grywna C Drosten, Proceedings of the Third European Congress of Virology: 15 September 2007; Nuernberg, Germany 2007
21. An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus. E Traggiai S Becker K Subbarao L Kolesnikova Y Uematsu MR Gismondo BR Murphy R Rappuoli A Lanzavecchia, Nat Med 2004 10 871 875 10.1038/nm1080 15247913 (Pubitemid 39070862)
22. SARS beginning to understand a new virus. K Stadler V Masignani M Eickmann S Becker S Abrignani HD Klenk R Rappuoli, Nat Rev Microbiol 2003 1 209 218 10.1038/nrmicro775 15035025
23. Specific epitopes of the structural and hypothetical proteins elicit variable humoral responses in SARS patients. SC Chow CY Ho TT Tam C Wu T Cheung PK Chan MH Ng PK Hui HK Ng DM Au AW Lo, J Clin Pathol 2006 59 468 476 16461566 10.1136/jcp.2005.029868
24. Identification of immunodominant epitopes on the membrane protein of the severe acute respiratory syndrome-associated coronavirus. Y He Y Zhou P Siddiqui J Niu S Jiang, J Clin Microbiol 2005 43 3718 3726 16081901 10.1128/JCM.43.8. 3718-3726.2005 (Pubitemid 41129651)
25. A Golgi retention signal in a membrane-spanning domain of coronavirus E1 protein. AM Swift CE Machamer, J Cell Biol 1991 115 19 30 1655802 10.1083/jcb.115.1.19
26. The cytoplasmic tail of mouse hepatitis virus M protein is essential but not sufficient for its retention in the Golgi complex. JK Locker J Klumperman V Oorschot MC Horzinek HJ Geuze PJ Rottier, J Biol Chem 1994 269 28263 28269 7961764
27. Expression of feline infectious peritonitis coronavirus antigens on the surface of feline macrophage-like cells. HE Jacobse-Geels MC Horzinek, J Gen Virol 1983 64 Pt 9 1859 1866 10.1099/0022-1317-64-9-1859 6886678
28. Expression of swine transmissible gastroenteritis virus envelope antigens on the surface of infected cells: epitopes externally exposed. MD Laviada SP Videgain L Moreno F Alonso L Enjuanes JM Escribano, Virus Res 1990 16 247 254 10.1016/0168-1702(90)90051-C 1697441 (Pubitemid 20223297)
29. Oligomerization of a trans-Golgi/trans-Golgi network retained protein occurs in the Golgi complex and may be part of its retention. JK Locker DJ Opstelten M Ericsson MC Horzinek PJ Rottier, J Biol Chem 1995 270 8815 8821 10.1074/jbc.270.15.8815 7721788
30. The E1 glycoprotein of an avian coronavirus is targeted to the cis Golgi complex. CE Machamer SA Mentone JK Rose MG Farquhar, Proc Natl Acad Sci USA 1990 87 6944 6948 2169615 10.1073/pnas.87.18.6944
31. Coronavirus E1 glycoprotein expressed from cloned cDNA localizes in the Golgi region. PJ Rottier JK Rose, J Virol 1987 61 2042 2045 3033331
32. The glycosylation status of the murine hepatitis coronavirus M protein affects the interferogenic capacity of the virus in vitro and its ability to replicate in the liver but not the brain. CA de Haan M de Wit L Kuo C Montalto-Morrison BL Haagmans SR Weiss PS Masters PJ Rottier, Virology 2003 312 395 406 10.1016/S0042-6822(03)00235-6 12919744 (Pubitemid 36960015)
33. Coronavirus particle assembly: primary structure requirements of the membrane protein. CA de Haan L Kuo PS Masters H Vennema PJ Rottier, J Virol 1998 72 6838 6850 9658133
34. Single amino acid changes in the viral glycoprotein M affect induction of alpha interferon by the coronavirus transmissible gastroenteritis virus. H Laude J Gelfi L Lavenant B Charley, J Virol 1992 66 743 749 1309909
35. The morphology of three previously uncharacterized human respiratory viruses that grow in organ culture. JD Almeida DA Tyrrell, J Gen Virol 1967 1 175 178 10.1099/0022-1317-1-2-175 4293939
36. Characterization of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) spike glycoprotein-mediated viral entry. G Simmons JD Reeves AJ Rennekamp SM Amberg AJ Piefer P Bates, Proc Natl Acad Sci USA 2004 101 4240 4245 15010527 10.1073/pnas.0306446101 (Pubitemid 38405913)
37. S protein of severe acute respiratory syndrome-associated coronavirus mediates entry into hepatoma cell lines and is targeted by neutralizing antibodies in infected patients. H Hofmann K Hattermann A Marzi T Gramberg M Geier M Krumbiegel S Kuate K Uberla M Niedrig S Pohlmann, J Virol 2004 78 6134 6142 15163706 10.1128/JVI.78.12.6134-6142.2004 (Pubitemid 38715911)
38. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. W Li MJ Moore N Vasilieva J Sui SK Wong MA Berne M Somasundaran JL Sullivan K Luzuriaga TC Greenough, Nature 2003 426 450 454 10.1038/nature02145 14647384 (Pubitemid 37490132)
39. Proteolytic cleavage of the E2 glycoprotein of murine coronavirus: host-dependent differences in proteolytic cleavage and cell fusion. MF Frana JN Behnke LS Sturman KV Holmes, J Virol 1985 56 912 920 2999444
40. Furin cleavage of the SARS coronavirus spike glycoprotein enhances cell-cell fusion but does not affect virion entry. KE Follis J York JH Nunberg, Virology 2006 350 358 369 10.1016/j.virol.2006.02.003 16519916 (Pubitemid 43928105)
41. Generation of synthetic severe acute respiratory syndrome coronavirus pseudoparticles: implications for assembly and vaccine production. Y Huang ZY Yang WP Kong GJ Nabel, J Virol 2004 78 12557 12565 15507643 10.1128/JVI.78.22. 12557-12565.2004 (Pubitemid 39458774)
42. Protein interactions during coronavirus assembly. V-P Nguyen BG Hogue, J Virol 1997 71 9278 9284 9371586
43. Complex formation between the spike protein and the membrane protein during mouse hepatitis virus assembly. DJ Opstelten MC Horzinek PJ Rottier, Adv Exp Med Biol 1993 342 189 195 8209729
44. Intracellular targeting signals contribute to localization of coronavirus spike proteins near the virus assembly site. E Lontok E Corse CE Machamer, J Virol 2004 78 5913 5922 15140989 10.1128/JVI.78.11.5913-5922.2004 (Pubitemid 38661679)
45. A novel sorting signal for intracellular localization is present in the S protein of a porcine coronavirus but absent from severe acute respiratory syndrome-associated coronavirus. C Schwegmann-Wessels M Al-Falah D Escors Z Wang G Zimmer H Deng L Enjuanes HY Naim G Herrler, J Biol Chem 2004 279 43661 43666 10.1074/jbc.M407233200 15304515 (Pubitemid 39390669)
46. The cytoplasmic tail of the severe acute respiratory syndrome coronavirus spike protein contains a novel endoplasmic reticulum retrieval signal that binds COPI and promotes interaction with membrane protein. CE McBride J Li CE Machamer, J Virol 2007 81 2418 2428 17166901 10.1128/JVI.02146-06 (Pubitemid 46303358)
47. Mapping of the coronavirus membrane protein domains involved in interaction with the spike protein. C de Haan M Smeets F Vernooij H Vennema P Rottier, J Virol 1999 73 7441 7452 10438834
48. Generation of bovine respiratory syncytial virus (BRSV) from cDNA: BRSV NS2 is not essential for virus replication in tissue culture, and the human RSV leader region acts as a functional BRSV genome promoter. UJ Buchholz S Finke KK Conzelmann, J Virol 1999 73 251 259 9847328
49. Multivesicular bodies as a platform for formation of the Marburg virus envelope. L Kolesnikova B Berghofer S Bamberg S Becker, J Virol 2004 78 12277 12287 15507615 10.1128/JVI.78.22.12277-12287.2004 (Pubitemid 39458747)